Topcon Healthcare Announces Investment in Senseye to Advance Mental Health Diagnostics Through Ocular Biomarkers
Summary
Topcon Healthcare invested in Senseye to expand mental health diagnostics using ocular biomarkers. Senseye uses AI and computer vision on smartphone-captured eye data to generate digital biomarkers for conditions such as PTSD, major depressive disorder, and generalized anxiety disorder. Topcon plans to connect Senseye’s technology with its Harmony platform to build new diagnostic modules and improve clinical insight. The company positions the investment as part of a broader strategy to extend eye-based healthcare data into psychiatry and related care pathways.
Funding
Amount
None
Total raised
Date
September 10, 2025
Announcement date
Investors
Topcon Healthcare Solutions
Lead investors
Company
senseye.co
Funded company
Classifications
industries
InsurTech
applications
Web and Content Management
AskAI Classifications
Labels
SaaS
Digital Health Software
AI/ML Software
Linked Companies
Senseye
$1M to $5M